Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|15|9|1323-1329

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.15, Iss.9, 2018-11, pp. : 1323-1329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery

By  

Current Drug Targets, Vol. 19, Iss. 3, 2018-02 ,pp. : 248-258

Bentham Science Publishers

Access to resources Recommend Favorite

Aptamer-Mediated Cancer Gene Therapy

By  

Current Gene Therapy, Vol. 15, Iss. 2, 2015-04 ,pp. : 109-119

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer

By Taghdisi Seyed Mohammad   Danesh Noor Mohammad   Sarreshtehdar Emrani Ahmad   Tabrizian Kaveh   ZandKarimi Majid   Ramezani Mohammad   Abnous Khalil  

Journal of Drug Targeting, Vol. 21, Iss. 8, 2013-09 ,pp. : 739-744

Informa Healthcare

Access to resources Recommend Favorite

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

By  

Current Cancer Drug Targets, Vol. 18, Iss. 4, 2018-04 ,pp. : 347-354

Bentham Science Publishers

Access to resources Recommend Favorite

Hyaluronan/Hyaladherins - a Promising Axis for Targeted Drug Delivery in Cancer

By  

Current Drug Delivery, Vol. 13, Iss. 4, 2016-06 ,pp. : 500-511

Bentham Science Publishers

Access to resources Recommend Favorite